Lanxess trims top of 2026 EBITDA range to €500 million, CEO sees no lasting demand recovery
dpa-AFX via FinanzNachrichten · · AI-summarised by FinFlash
German specialty chemicals group Lanxess now targets 2026 EBITDA before special items at the upper end of 450-500 million euros, having previously guided to 450-550 million. Third-quarter sales rose almost 10% to about 1.47 billion euros, and operating earnings gained just over 11% to 139 million euros. A net loss of 70 million euros remained. CEO Matthias Zachert said agrochemicals, autos and construction are still far from a broad recovery. Shares were indicated 5% higher pre-market.
So What?
The positive pre-market reaction suggests investors had feared worse, but the CEO's comments are a cautious signal for European chemicals peers. Watch whether the rise holds at the Xetra open.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.